Ticker >

Nureca Ltd. share price

Nureca Ltd.

NSE: NURECA BSE: 543264 SECTOR: Medical Equipment/Supplies/Accessories  80k   296   20

311.65
+10.25 (3.40%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 314.65

Today's Low

₹ 303.6

52 Week High

₹ 468.25

52 Week Low

₹ 240.9

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

311.66 Cr.

Enterprise Value

266.85 Cr.

No. of Shares

1 Cr.

P/E

0

P/B

1.61

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  194.05

CASH

45.2 Cr.

DEBT

0.4 Cr.

Promoter Holding

63.77 %

EPS (TTM)

₹  -0.51

Sales Growth

-15.53%

ROE

-1.26 %

ROCE

-1.45%

Profit Growth

71 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Nureca Ltd.

Dr. Trust Dr. Physio Trumom

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-15.53%
3 Year-23.76%
5 Year164.59%

Profit Growth

1 Year71%
3 Year-137.44%
5 Year-359.51%

ROE%

1 Year-1.26%
3 Year6.4%
5 Year32.64%

ROCE %

1 Year-1.45%
3 Year8.97%
5 Year34.13%

Debt/Equity

0.0021

Price to Cash Flow

-103.99

Interest Cover Ratio

-6.1065

CFO/PAT (5 Yr. Avg.)

0.436302051745643

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 63.77 0
Jun 2024 63.24 0
Mar 2024 63.24 0
Dec 2023 63.24 0
Sep 2023 63.24 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 21.5798.
  • The company has a high promoter holding of 63.77%.

 Limitations

  • The company has shown a poor profit growth of -137.439073379198% for the Past 3 years.
  • The company has shown a poor revenue growth of -23.7641422083496% for the Past 3 years.
  • Company has a poor ROE of 6.4031% over the past 3 years.
  • Company has negative cash flow from operations of -2.997.
  • The company is trading at a high EV/EBITDA of 101.35.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 21.23 31.35 22.37 19.56 23.31
Total Expenditure 24.22 30.31 26.8 24.32 26.23
Operating Profit -2.98 1.04 -4.43 -4.76 -2.91
Other Income 2.69 3.21 5.92 -1.25 5.82
Interest 0.11 0.08 0.1 0.17 0.13
Depreciation 0.56 0.56 0.56 0.56 0.61
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.96 3.61 0.83 -6.74 2.16
Tax -0.22 0.97 0.75 -2.33 0.97
Profit After Tax -0.74 2.64 0.08 -4.41 1.2
Adjusted EPS (Rs) -0.74 2.64 0.08 -4.41 1.2

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 99.43 213.33 255.55 111.9 94.52
Total Expenditure 89.72 151.65 199.78 127.29 105.67
Operating Profit 9.71 61.68 55.77 -15.39 -11.15
Other Income 0.06 2.82 7.72 7.17 10.58
Interest 0.77 1.6 0.73 0.43 0.46
Depreciation 0.37 0.41 1.43 2.3 2.24
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.62 62.49 61.33 -10.96 -3.27
Tax 2.21 15.96 16.02 -2.54 -0.83
Net Profit 6.41 46.53 45.31 -8.42 -2.44
Adjusted EPS (Rs.) 915.71 46.53 45.31 -8.42 -2.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.01 10 10 10 10
Total Reserves 14.96 153.29 193.74 185.26 182.86
Borrowings 9.35 0.78 0 0 0.33
Other N/C liabilities 0.06 2.46 3.59 0.11 -2.5
Current liabilities 9.45 33.88 45.14 8.62 8.77
Total Liabilities 33.83 200.41 252.48 203.98 199.46
Assets
Net Block 1.06 3.37 9.78 8.08 6.33
Capital WIP 0 0 0 0 0
Intangible WIP 0 0.3 0.42 0 0
Investments 0.05 0.82 1.31 3.06 3.06
Loans & Advances 0.03 0.09 0.26 1.61 0.92
Other N/C Assets 0 0 1.95 7.24 0
Current Assets 32.69 195.84 238.76 184 189.15
Total Assets 33.83 200.41 252.48 203.98 199.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 8.62 62.49 61.33 -10.96 -3.27
Adjustment 1.16 0.09 -3.79 -3.64 -6.98
Changes in Assets & Liabilities -17.63 -12.42 -37.76 30.78 5.76
Tax Paid -0.01 -15.07 -17.96 -4.14 1.49
Operating Cash Flow -7.85 35.1 1.83 12.05 -3
Investing Cash Flow -0.39 -110.48 -3.37 -18.3 17.84
Financing Cash Flow 8.2 92.34 -7.3 -1.51 -1.28
Net Cash Flow -0.05 16.96 -8.84 -7.76 13.56

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 63.24 63.24 63.24 63.24 63.77
aryan goyal - - - - 3.63
nectar biopharma private ... - - - - 0.54
payal goyal - - - - 27.98
saurabh goyal - - - - 31.62
aryan goyal 3.76 3.76 3.76 3.76 -
payal goyal 27.98 27.98 27.98 27.98 -
saurabh goyal 31.49 31.49 31.49 31.49 -
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Sep 2024%
investors 30.00 30.00 30.00 30.00 36.23
llp 0.05 - - - 0.02
hornbill orchid india fun... 3.89 3.89 3.89 1.44 -
nexpact limited 8.28 7.50 7.32 - -
next orbit ventures fund 4.08 3.88 3.88 - -
quant mutual fund - quant... 1.35 1.35 1.35 - -
yash shares and stock pri... 4.41 3.41 3.41 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationQ4FY24 16 May 2024
  • PresentationQ3FY24 10 Feb 2024
  • PresentationQ2FY24 9 Nov 2023
  • PresentationQ1FY22 5 Oct 2021

Company News

Nureca informs about closure of trading window 26 Sep 2024, 4:26PM Nureca enters into distribution agreement to make products available on commerce platform17 Sep 2024, 12:42PM Nureca Ltd. - Quaterly Results5 Aug 2024, 5:11PM Nureca Ltd. - Quaterly Results5 Aug 2024, 5:11PM Nureca Ltd. - Quaterly Results5 Aug 2024, 5:11PM Nureca Ltd. - Quaterly Results15 May 2024, 11:51AM Nureca Ltd. - Quaterly Results15 May 2024, 11:51AM Nureca Ltd. - Quaterly Results15 May 2024, 11:51AM Nureca informs about compliance certificate9 Apr 2024, 2:17PM Nureca’s Dr Trust recognized as ‘Well Known Trademark’ by Indian Trademark Registry2 Apr 2024, 6:07PM Nureca informs about press release 1 Mar 2024, 1:24PM Nureca informs about press release8 Feb 2024, 5:02PM Nureca Ltd. - Quaterly Results7 Feb 2024, 5:24PM Nureca Ltd. - Quaterly Results7 Feb 2024, 5:24PM Nureca Ltd. - Quaterly Results7 Feb 2024, 5:24PM Nureca Ltd. - Quaterly Results4 Nov 2023, 5:17PM Nureca Ltd. - Quaterly Results4 Nov 2023, 5:17PM Nureca Ltd. - Quaterly Results4 Nov 2023, 5:17PM Nureca Ltd. - Quaterly Results10 Aug 2023, 5:55PM Nureca Ltd. - Quaterly Results10 Aug 2023, 5:55PM Nureca Ltd. - Quaterly Results23 May 2023, 8:01PM Nureca Ltd. - Quaterly Results23 May 2023, 8:01PM Nureca informs about secretarial compliance report17 May 2023, 5:08PM Nureca Ltd. - Quaterly Results3 Feb 2023, 6:28PM Nureca Ltd. - Quaterly Results3 Feb 2023, 6:28PM Nureca informs about board meeting28 Jan 2023, 12:33PM Nureca informs about disclosure of related party transactions26 Nov 2022, 3:20PM Nureca Ltd. - Quaterly Results11 Nov 2022, 6:38PM Nureca Ltd. - Quaterly Results11 Nov 2022, 6:38PM Nureca’s arm obtains ISO 13485:2016 certification for Indian medical device facility8 Oct 2022, 3:06PM Nureca submits press release8 Oct 2022, 12:21PM Nureca Ltd. - Quaterly Results12 Aug 2022, 7:12PM Nureca Ltd. - Quaterly Results12 Aug 2022, 7:12PM Nureca Ltd. - Quaterly Results28 May 2022, 11:47PM Nureca Ltd. - Quaterly Results28 May 2022, 11:47PM Nureca informs about outcome of board meeting14 Feb 2022, 10:01AM Nureca Ltd. - Quaterly Results12 Feb 2022, 9:55PM Nureca Ltd. - Quaterly Results12 Feb 2022, 9:55PM Nureca informs about change of registered office of the Company1 Dec 2021, 10:39AM Nureca informs about closure of trading window30 Sep 2021, 1:34PM Nureca informs about virtual meet 2 Aug 2021, 10:46AM Nureca informs about virtual meet18 Jun 2021, 10:04AM Nureca informs about resignation of CFO16 Jun 2021, 4:51PM Nureca informs about press release10 May 2021, 10:07AM Nureca coming with an IPO to raise upto Rs 100 crore11 Feb 2021, 1:41PM

Nureca Ltd. Stock Price Analysis and Quick Research Report. Is Nureca Ltd. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Nureca Ltd. stock price today is Rs 313.4. So, let’s look into Nureca Ltd. and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs -2.997 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Nureca Ltd. has a Debt to Equity ratio of 0.0021 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Nureca Ltd. , the EPS growth was 71.0045 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Nureca Ltd. has OPM of -11.7973783603644 % which is a bad sign for profitability.
     
  • ROE: Nureca Ltd. have a poor ROE of -1.2584 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Nureca Ltd. is Rs 313.4. One can use valuation calculators of ticker to know if Nureca Ltd. share price is undervalued or overvalued.
Last Updated on:
Brief about Nureca Ltd.
X